Australian babies with peanut allergies will be offered oral immunotherapy in a world-first program.
Ten pediatric hospitals across five states have partnered with the National Allergy Centre of Excellence (NACE), hosted at Murdoch Children's Research Institute (MCRI), to be the first globally to introduce a nation-wide peanut oral immunotherapy program into mainstream care.
About three in every 100 Australian children have a peanut allergy, which is usually treated by strictly avoiding nuts in diets.